Cspc Pharmaceutical | 1093 - Eps Gewinn Pro Aktie

Aktienkurs
8.98
Täglich Wechseln
0.06 0.67%
Monatlich
5.77%
Jährlich
46.97%
Q2 Prognose
8.80

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2027Q1 Mar/2026 0.1 0.13 May/27




Eps Veränderung Datum
Akebia Therapeutics USD -0.04 0.04 2025-12
Alaunos Therapeutics USD -0.53 0.08 2025-09
Avita Medical AUD -0.38 0 2025-12
Cspc Pharmaceutical CNY 0 0.08 2025-12
Dianthus Therapeutics USD -1.43 0.46 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
IQVIA Holdings USD 3.42 0.42 2025-12
Jiangsu Hengrui CNY 0.34 0.05 2026-03
Kangmei Pharma CNY 0 0 2025-09
Moderna USD -2.11 1.6 2025-12
Organon & Co USD 0.63 0.38 2025-12
Revvity USD 1.7 0.52 2025-12
Sh Fosun Pharma CNY 0.29 0.01 2026-03
Sino Biopharmaceutical CNY -0.06 0.22 2025-12
Tectonic Therapeutic USD -1.03 0.01 2025-12
Viatris USD 0.57 0.1 2025-12
Wuxi Apptec CNY 2.47 0.06 2026-12
Xeris Pharmaceuticals USD 0.05 0.05 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 1.53 0.8 2025-09